Bearz, Alessandra
59  results:
Search for persons X
?
 
?
10

Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) Wit..:

Cho, Byoung Chul ; Obermannova, Radka ; Bearz, Alessandra...
Cho , B C , Obermannova , R , Bearz , A , McKeage , M , Kim , D-W , Batra , U , Borra , G , Orlov , S , Kim , S-W , Geater , S L , Postmus , P E , Laurie , S A , Park , K , Yang , C-T , Ardizzoni , A , Bettini , A C , de Castro , G , Kiertsman , F , Chen , Z , Lau , Y Y , Viraswami-Appanna , K , Passos , V Q & Dziadziuszko , R 2019 , ' Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study ' , Journal of Thoracic Oncology , vol. 14 , no. 7 , pp. 1255-1265 . https://doi.org/10.1016/j.jtho.2019.03.002.  , 2019
 
?
13

Brigatinib versus crizotinib in ALK-positive non-small-cell..:

Camidge, D. Ross ; Kim, Hye Ryun ; Ahn, Myung-Ju...
New England Journal of Medicine, Vol.379 No.21, pp.2027-2039.  , 2018
 
?
 
1-15